Esketamine: Regulators and a confusing narrative

I recently shared a BMJ report that outlined the approval of Esketamine in Europe: Since sharing this news, the following rapid response by the MHRA [The Medicines and Healthcare products … Continue reading Esketamine: Regulators and a confusing narrative

“Esketamine is approved in Europe”

The BMJ has published this News report, the full article can be accessed here.

Trainees’ Workshop

As part of the 2019 Summer Meeting the British Association for Psychopharmacology has organised a ‘Trainees’ Workshop’ chaired by Professor Jeremy Hall and with the following five speakers: I have … Continue reading Trainees’ Workshop

“A wrong un’ when you see it”

The January 2019 edition of the British Journal of Psychiatry has, as its theme: Treatment-Resistant Mood Disorders. In the Journal a “consensus definition” of “treatment resistance” was provided by a … Continue reading “A wrong un’ when you see it”

The British Journal of Psychiatry: are competing interests of authors sufficiently transparent?

The current edition of the British Journal of Psychiatry, May 2018, contains academic papers on depressive disorders. In this post I will share some of the declarations of interest linked … Continue reading The British Journal of Psychiatry: are competing interests of authors sufficiently transparent?